Table 1.

Rotavirus shedding in stool on days 3-7 post administration of RV3-BB or placebo. Neonate and Infant schedule participants received RV3-BB vaccine according the dosing schedule described in Material and methods.

	IP dose 1 (0-5 days)	IP dose 2 (8 weeks)	IP dose 3 (15 weeks)	IP dose 4 (24 weeks)
Neonate Schedule	13.3% (4/30)	63.3% (19/30)	53.3% (16/30)	0% (0/30)*
Infant Schedule	0% (0/27)*	62.9% (17/27)	48.1% (13/27)	37.0% (10/27)
Placebo	0% (0/32)*	0% (0/32)*	3.1% (1/32)*	0% (0/32)*

^*Placebo given at IP dose.